WHO THIS IS FOR
Built for five regulated sub-segments. From manufacturer to clinical user.
Health and life sciences spans medical disposables at $5M trade volume up to pharmaceutical APIs above $500M — held together by one thread. Non-compliance has consequences orders of magnitude beyond commercial loss: product recalls, FDA holds at customs, import refusal, license suspension. EDMA Group's own glove distribution business, across 9 countries, is the dogfood for everything on this page.
01 · DEVICESMedical devices
Class I / II / III devices, durable and capital equipment. FDA 510(k) / PMA, CDRH oversight, EU MDR, ISO 13485 quality system. UDI serialization required; engineering documentation overlaps with industrial B2B but compliance is the driver.
What's distinctEvery unit carries a UDI tied back to lot & design history file.
RegulatoryFDA 510(k) / PMA · EU MDR · ISO 13485Cold chainNot requiredVolume band$10M–$250M
02 · DISPOSABLESMedical disposables & consumables
Gloves, masks, syringes, gowns, surgical instruments. Volume-based distribution from Asian factories to global health systems — the exact business EDMA Group runs every day across 9 countries. Every workflow on this page has been pressure-tested against real disposable gloves operations.
What's distinctLot economics live or die on container-level QC and country-of-destination filings.
RegulatoryFDA reg. · CE mark · ISO 13485 (higher class)Cold chainConditional · sterile onlyVolume band$5M–$200M+
03 · IVDsIn-vitro diagnostics
Test kits, reagents, lab consumables, calibrators, controls. EU IVDR now fully in effect; FDA CDRH oversight in the US. Batch-specific quality control runs on every shipment; biologics-containing kits require active cold chain.
What's distinctCold chain is critical for biologics; batch QC must travel with the lot.
RegulatoryFDA CDRH · EU IVDR · ISO 13485Cold chainRequired for biologicsVolume band$8M–$150M
04 · PHARMAPharmaceuticals & APIs
Finished drugs plus active pharmaceutical ingredients. DSCSA serialization in the US, EU FMD verification, GMP audits across the chain, MAH letter chains across every market. Annex 11 / 21 CFR Part 11 system validation is the floor.
What's distinctThe heaviest regulatory weight of the five — serialization down to the saleable unit.
RegulatoryDSCSA · EU FMD · GMP · 21 CFR Part 11Cold chainRequired · many productsVolume band$50M–$500M+
05 · CONSUMER HEALTHConsumer health, wellness & supplements
OTC drugs, dietary supplements, nutraceuticals, vitamins. FTC claims compliance, FDA CFSAN oversight, GMP for dietary supplements (21 CFR Part 111). Lighter than pharma but still meaningful audit requirements — especially on health claims and label content.
What's distinctClaims compliance is its own audit surface, separate from the product.
RegulatoryFDA CFSAN · FTC claims · 21 CFR 111Cold chainRarely requiredVolume band$3M–$100M